Xilio Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Xilio Therapeutics generated cash of -$68,620,000, which is more than the previous year. Cash used in financing activities reached the amount of -$6,550,000 last year. Net change in cash is therefore -$75,656,000.
Cash Flow
| 2019 | -17.84M | -715K | 60.02M |
|---|---|---|---|
| 2020 | -36.09M | -2.18M | 10.02M |
| 2021 | -80.75M | -1.1M | 260.66M |
| 2022 | -75.72M | -1.86M | -69K |
| 2023 | -68.62M | -486K | -6.55M |
XLO Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 121.94M | 199.60M | 20.78M | 49.03M | 7.57M |
Operating activities | |||||
Net income | -76.40M | -88.22M | -75.8M | -55.21M | -17.31M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.9M | 1.84M | 1.49M | 1.06M | 240K |
Stock-based compensation expense | 7.38M | 8.42M | 4.95M | 1.29M | 112K |
| Deferred income tax benefit | 7.38M | 8.42M | 4.95M | 1.29M | 112K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -2.06M | 485K | -2.81M | 2.92M | 970K |
Cash generated by operating activities | -68.62M | -75.72M | -80.75M | -36.09M | -17.84M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -486K | -1.86M | -1.1M | -2.18M | -715K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -486K | -1.86M | -1.1M | -2.18M | -715K |
Financing activities | |||||
Common Stock Issued | 202K | 16K | 116.35M | 10.12M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 194K | 0 | 0 | 0 | 0 |
Repayments of term debt | -6.75M | -85K | -1.08M | -99K | 9.95M |
Cash used in financing activities | -6.55M | -69K | 260.66M | 10.02M | 60.02M |
Net Change In Cash | -75.65M | -77.65M | 178.81M | -28.25M | 41.46M |
Cash at end of period | 46.29K | 121.94M | 199.60M | 20.78M | 49.03M |
| Data source | Data source | Data source |